Ahmad Sadr
Corporate Officer/Principal en APELLIS PHARMACEUTICALS, INC. .
Cargos activos de Ahmad Sadr
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
| Director Técnico/Científico/I+D | 01/01/2017 | - |
Historial de carrera de Ahmad Sadr
Antiguos cargos conocidos de Ahmad Sadr.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2016 | 01/01/2017 |
Vision Medicines, Inc.
 Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Director Técnico/Científico/I+D | 01/04/2015 | 01/05/2016 |
Formación de Ahmad Sadr.
| University of Maryland | Undergraduate Degree |
| Widener University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Ahmad Sadr
- Experiencia
